skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.06d (Release date: 2017-06-26)
SearchBox Top
SearchBox Bottom
VCL-CB01 Vaccine (Code C61327)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: VCL-CB01 Vaccine

Definition: A vaccine consisting of two plasmids encoding the human cytomegalovirus (CMV) tegument phosphoprotein 65 (pp65), a major internal matrix protein, and glycoprotein B (gB), an important CMV component responsible for attachment and entry into cells, with immunostimulatory properties. Vaccination with VCL-CB01 may stimulate the host immune system to mount cellular and humoral immune responses against CMV positive cells, resulting in cell lysis.

Display Name: VCL-CB01 Vaccine

Label: VCL-CB01 Vaccine

NCI Thesaurus Code: C61327 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1831826  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
VCL-CB01 Vaccine

External Source Codes: 
PDQ Closed Trial Search ID 485276
PDQ Open Trial Search ID 485276 (check for NCI PDQ open clinical trial info)
UMLS CUI C1831826

Other Properties:
     Name Value (qualifiers indented underneath)
code C61327
Contributing_Source CTRP
Legacy_Concept_Name VCL-CB01_Vaccine
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom